Lung Cancer News and Research

Latest Lung Cancer News and Research

Novartis' new drug combination receives positive CHMP opinion for treating stage III BRAF mutant melanoma

Novartis today announced the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion recommending approval of Tafinlar® in combination with Mekinist® for the adjuvant treatment of adult patients with stage III melanoma with a BRAF V600 mutation, following complete resection.

27 Jul 2018

Most smokers seem to be confused about actual benefits of lung cancer screenings

Regular cancer screenings can lower the chance of death from lung cancer. But they cannot reduce the risk of developing lung cancer for people who smoke.

26 Jul 2018

CNDA approves KEYTRUDA for treatment of advanced melanoma

Merck, known as MSD outside the United States and Canada, today announced that KEYTRUDA, Merck's anti-PD-1 therapy, has been approved by the China National Drug Administration for the treatment of adult patients with unresectable or metastatic melanoma following failure of one prior line of therapy.

26 Jul 2018

Newly identified target may lead to discovery of treatments for chronic inflammatory diseases

Inflammation is part of the body's natural healing process. But when it becomes chronic, inflammation can lead to cancer, Alzheimer's disease and other conditions.

26 Jul 2018

New combination approach may help crush resistance to treatment in lung cancer patients

New-generation lung cancer drugs have been effective in a large number of patients, but within about a year, the patients tend to develop resistance to the therapy.

26 Jul 2018

Phase 3 study of KEYTRUDA monotherapy meets primary endpoint

Merck, known as MSD outside the United States and Canada, announced today that the pivotal Phase 3 KEYNOTE-048 trial investigating KEYTRUDA, Merck's anti-PD-1 therapy, for first-line treatment of recurrent or metastatic head and neck squamous cell carcinoma, met a primary endpoint of overall survival as monotherapy in patients whose tumors expressed PD-L1.

25 Jul 2018

Study: Blood test can predict response of advanced prostate cancer patients to treatments

An international collaborative study between Lawson Health Research Institute, Memorial Sloan Kettering Cancer Center, the Royal Marsden and Epic Sciences is one of the first to demonstrate that a blood test can predict how patients with advanced prostate cancer will respond to specific treatments, leading to improved survival.

25 Jul 2018

New study shows why winter air pollution levels have remained high in the United States

The air in the United States is much cleaner than even a decade ago. But those improvements have come mainly in summer, the season that used to be the poster child for haze-containing particles that cause asthma, lung cancer and other illnesses.

24 Jul 2018

Analysis reveals disparities in cancer death rates among minority groups

Analysis of cancer death data from 2008-2014 in New York state revealed high cancer mortality rates among U.S.-born blacks and Puerto Ricans and relatively low cancer mortality rates among Hispanic South Americans and Asians.

19 Jul 2018

Cancer patients receiving anti-PD-1 therapies may experience delayed skin reactions

Cancer patients receiving anti-PD-1 therapies who develop lesions, eczema, psoriasis, or other forms of auto-immune diseases affecting the skin may experience those adverse reactions on a delay – sometimes even after treatment has concluded.

19 Jul 2018

Conservative management of lung subsolid nodules reduces overtreatment and unnecessary surgery

Subsolid nodules can be considered a biomarker of lung cancer risk and should be managed with long-term active surveillance.

18 Jul 2018

Researchers reduce size of tumors in mice by artificially activating the brain's reward system

By artificially activating the brain's reward system, researchers at the Technion-Israel Institute of Technology have dramatically reduced the size of cancerous tumors in mice. The findings were published recently in the journal Nature Communications.

16 Jul 2018

Four-protein biomarker blood test improves lung cancer risk assessment for smokers

A four-protein biomarker blood test improves lung cancer risk assessment over existing guidelines that rely solely upon smoking history, capturing risk for people who have ever smoked, not only for heavy smokers, an international research team reports in JAMA Oncology.

12 Jul 2018

Targeting amino acid transporter may improve survival rates for non-small cell lung cancer patients

An amino acid transporter named xCT may affect the growth and progression of non-small cell lung cancer, a discovery that may predict the five-year survival rate of patients suffering from this cancer, now at 16 percent, researchers at Georgia State University and Vanderbilt University Medical Center have concluded.

11 Jul 2018

American Cancer Society outlines vision for cancer control in the decades ahead

The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that begins publishing today.

11 Jul 2018

Study explores occurrence and treatment of brain metastases in ROS1 lung cancer

Increasingly, doctors are treating lung cancer based on the genetic rearrangements driving the disease. For example, cancers that are driven by changes in the genes ALK, EGFR, and ROS1 can now all be paired with drugs that target these specific changes.

10 Jul 2018

Lung Cancer News and Research

Latest Lung Cancer News and Research

Novartis' new drug combination receives positive CHMP opinion for treating stage III BRAF mutant melanoma

Most smokers seem to be confused about actual benefits of lung cancer screenings

CNDA approves KEYTRUDA for treatment of advanced melanoma

Newly identified target may lead to discovery of treatments for chronic inflammatory diseases

New combination approach may help crush resistance to treatment in lung cancer patients

Phase 3 study of KEYTRUDA monotherapy meets primary endpoint

Study: Blood test can predict response of advanced prostate cancer patients to treatments

New study shows why winter air pollution levels have remained high in the United States

Analysis reveals disparities in cancer death rates among minority groups

Cancer patients receiving anti-PD-1 therapies may experience delayed skin reactions

Conservative management of lung subsolid nodules reduces overtreatment and unnecessary surgery

Researchers reduce size of tumors in mice by artificially activating the brain's reward system

Four-protein biomarker blood test improves lung cancer risk assessment for smokers

Targeting amino acid transporter may improve survival rates for non-small cell lung cancer patients

American Cancer Society outlines vision for cancer control in the decades ahead

Study explores occurrence and treatment of brain metastases in ROS1 lung cancer

Researchers develop simple blood test to predict likely spread of rare cancer

Researchers find new metabolic vulnerability in small cell lung cancer

Geriatric assessments could fine-tune cancer care for older adults

Researchers receive grant to evaluate efficacy of tobacco cessation methods

The ultimate guide to lung research tools and protocols eBook

How does norepinephrine influence anxiety-related behaviours?

Transforming Lab Workflows with Cell Culture Automation

Building Bridges to Scalable Allogeneic Cell Therapy

Lung Cancer News and Research

Latest Lung Cancer News and Research

The ultimate guide to lung research tools and protocols eBook

How does norepinephrine influence anxiety-related behaviours?

Transforming Lab Workflows with Cell Culture Automation

Building Bridges to Scalable Allogeneic Cell Therapy

Newsletters you may be interested in